Table 1.
Groups | n |
Phenotype |
Allele |
|||||
E2/3(%) | E2/4(%) | E3/3(%) | E3/4(%) | ε2(%) | ε3(%) | ε4(%) | ||
Patients | 87 | 10(11.4) | 0 | 69(79.4) | 8(9.2) | 5.8 | 89.6 | 4.6 |
Male | 39 | 4(10.2) | 0 | 31(79.4) | 4(10.2) | 5.1 | 89.8 | 5.1 |
Female | 48 | 6(12.5) | 0 | 38(79.1) | 4(8.9) | 6.3 | 89.6 | 4.2 |
Controls | 50 | 5(10.0) | 2(4.0) | 37(74.1) | 6(12.0) | 7.0 | 85.0 | 8.0 |
Male | 27 | 3(10.0) | 1(3.7) | 20(74.0) | 3(11.0) | 7.4 | 85.2 | 7.4 |
Female | 23 | 2(8.6) | 1(4.3) | 17(74.6) | 3(13.0) | 6.5 | 84.8 | 8.7 |